Antimicrobial Activity of Actinomycetes Isolated from Different soil samples of Vellore Region
Nirmala Devi P, Sudesh Warma S, Srinivasan M, Merlyn Keziah. S, Subathra Devi C*
School of Biosciences and Technology, VIT University, Vellore, Tamil Nadu, India.
*Corresponding Author E-mail: subaresearch@rediffmail.com
ABSTRACT:
The main objective of the present study was isolation, purification, and characterization of actinomycetes from soil samples. Soil samples were taken from different niche habitats of Vellore district, Tamil Nadu, India. Potential isolate was screened morphologically and biochemically characterised, further were subjected to extraction for the creation of the antibacterial compound. The strains JS26, JS27, and JS28 were discovered profoundly potential, Isolate JS27 displayed the most noteworthy activity against Bacillus cereus (22 mm) and Enterococcus faecalis (25 mm). Ethyl acetate extract showed 89% restraint towards free radicals DPPH (1,1-Diphenyl-2-picrylhydrazyl). The gas chromatography-mass spectroscopy (GC-MS) demonstrated the few unstable mixes. Consequently the outcome showed that the ethyl acetate concentrate of confine groups have tendency to prevent cancer and could be utilized as a part of the advancement of new bioactive metabolites for pharmaceutical purposes.
KEYWORDS: Actinomycetes, antimicrobial activity, pathogens,ant-oxidants,bioactivity
INTRODUCTION:
Soil microorganisms give a brilliant asset to the seclusion and distinguishing proof of restoratively imperative items. Among them, actinomycetales are a vital gathering.1 The request actinomycetales is made out of roughly 80 genera, about all from earthbound soils, where they live essentially as saprophytes, water and colonizing plants demonstrating stamped synthetic and morphological differences, yet from a particular developmental line2 Actinomycetes are gram-positive microorganisms with high guanine+cytosine substance of more than 55%3 in their DNA, which have been perceived as wellsprings of a few auxiliary metabolites, anti-toxins, and bioactive exacerbates that influence microbial development.4 Actinomycetes have filamentous nature, expanding example, and conidia development, which are like those of growths. Therefore, they are otherwise called beam organisms5 Actinomycetes create expanding mycelium viz.; substrate and aerial mycelium.
Streptomyces are the predominant of all actinomycetes6 Countless have been separated and screened from soil in the previous a very long while, representing 70%-80% of pertinent optional metabolites accessible monetarily.7 Actinomycetes are potential wellspring of numerous bioactive mixes8,9,10,11 which have different clinical impacts and imperative applications in human pharmaceutical.12 It has been assessed that around 33% of the a huge number of normally happening anti-microbials has been acquired from actinomycetes.13 Oxidative push is a vital patron to the patho-physiology of an assortment of obsessive conditions, including cardiovascular brokenness, atherosclerosis, aggravation, carcinogenesis, sedate harmfulness, and reperfusion damage and neurodegenerative illnesses.14 Cell reinforcement assumes a critical part in the avoidance of pathologies, in which responsive oxygen species (ROS) are ensnared.15 They are sure normally happening cell reinforcements that can offer insurance to liver from hepatotoxins. The resistance issue requests to find new antibacterial specialists successful against safe pathogenic microscopic organisms and parasites. In this way, we have to screen increasingly actinomycetes from various environments for antimicrobial action in the trust of getting some new actinomycetes strains that deliver anti-microbials, which have not been found yet and are dynamic against medication safe pathogens. Nowadays research is currently coordinated towards normal cancer prevention agents from plants and microorganisms and serves as protected therapeutics. Accordingly, this study was proposed to develop the cancer prevention agent and antibacterial properties of actinomycetes source.
MATERIALS AND METHODS:
Soil Sampling and Pre treatment:
Soil tests were gathered from various specialty natural surroundings of Vellore locale (topographical directions: scope 25.67°N and longitude 76.7°E), Tamilnadu, India. Soils were gathered from various areas of Vellore, for example, field, close plant surface, poultry homestead, and well. Tests were gathered by embeddings a disinfected polyvinyl corer into the dregs. The cover was cleaned with liquor before inspecting at every area. Every accumulation was produced using 6-12 inches profundity of the surface of the ground. These examples were put in sterile poly packs, fixed firmly, and transported quickly to the research facility.16
Isolation of actinomycetes:
One gram of dried soil was suspended in 99 mL sterile water and serially weakened in sterile water up to 10−7. An aliquot of 0.1 mL of every weakening was taken and spread uniformly over the surface of actinomycete medium17,18 supplemented with cyclohexamide (50 μg/mL) and nystatin (50 μg/mL) Followed by incubation 7 days at 27°C.20,21
Morphological characterization :
Actinomycete isolates were inoculated on seven different ISP media (ISP1-ISP7) and incubated for 5 days at 30°C. The colonies were observed under a high-power magnifying lens and colony morphology was noted with respect to color, aerial and substrate mycelium, branching, and the nature of the colony.22
Biochemical characterization:
After preliminary studies, the isolates which were found to be positive were selected for biochemical studies. Biochemical tests generally used are gelatin hydrolysis, starch hydrolysis, urea hydrolysis, acid production from different sugars, hydrogen sulfide production test, motility test, triple sugar iron (TSI) agar test, citrate utilization test, indole test, methyl red test, Voges-Proskauer test, and catalase test, oxidase test.23
Test organism and screening for potent actinomycetes:
Test organisms were obtained from IMTECH, Chandigarh. The selected human pathogenic microorganisms used in antimicrobial study were Bacillus cereus MTCC 430, Enterococcus faecalis MTCC 29. Cross-streak strategy24 was used to screen the potential actinomycete isolates using Mueller Hinton Agar (MHA).
Extraction of bioactive compound:
Potent bioactive compound producing isolate JS27 was taken in 50 mL of ISP1 medium incubated for 7 days at 150 rpm.26 The supernatant was extracted at 10,000 rpm for 10 min to evacuate cells. Equal volume of ethyl acetate was added and left over for 24 h in a rotatory shaker. The totally dried deposits were re-broken down in dimethyl sulfoxide (DMSO) and lyophilized, to be utilized for further studies27, 28.
Determination of the antibacterial Activity:
Antibacterial activity was checked using by agar well diffusion assay. Cell Concentration of all test microorganisms was balanced at 0.5 McFarland turbidity guidelines and vaccinated on MHA plates by utilizing cleaned cotton swabs. Wells were exhausted by sanitizing 1000 μL small scale tip, and 100 μL of each JS27 rough concentrate was filled over the wells. Plates were brooded at 37°C for 24 h29.
DPPH free radical scavenging activity:
Essentially different concentrations (0.1, 0.5, 1.0 &5.0 mg/mL) of the JS27 ethyl acetate derivation were taken in a different tube and the ascorbic corrosive was utilized as reference compound (like 0.2, 0.4, 0.8, 1.0 and 5.0 mg/mL). Utilizing methanol to newly arranged the 0.002% DPPH (1,1 Diphenyl-2-Picrylhydrazyl) was added to every tube containing diverse centralizations of concentrates (2mL) for 37˚C at 20mins and measured at 515nm.30
Gas chromatography and mass spectroscopy (GC-MS) Analysis:
To identify the various bioactive compounds GC-MS technique was utilised. In this technique, interpretation was carried out though NIST08 and WILEY8. The relative percentage of each component was calculated by comparing its average peak area to the total areas.31,33
RESULTS:
Actinomycetes have been seriously concentrated on in a few underexplored situations, specialty, and extraordinary territories in different parts of the world (counting India) in the most recent couple of years. However, there is no report with respect to confinement of actinomycetes from vellore locale. An endeavour has been made to seclude the actinomycetes from this unexplored district keeping in mind the end goal to discover novel species. Absolutely 15 actinomycetes strains were disconnected from soil tests of various territories in view of the gram recoloring and state morphology. All the isolates were observed to be sure in grams staining and had distinctive morphological structures. The biochemical properties of actinomycetes isolates were recorded [Table 1, 2, 3; Fig 1].
Table 1: Morphological Properties of strain Streptomyces sp VITJS27
|
Morphological properties |
||||||
|
Sporophore morphology |
Spore surface |
Colour of aerial mycelium |
Colour of substrate mycelium |
Gram staining |
Acid fast staining |
Motility |
|
Spiral |
Smooth |
Ash |
Ash |
+ |
Non-acid fast |
- |
Table 2: Cultural properties of Streptomyces sp VITJS27
|
Medium |
Growth |
|
ISP medium 1 |
Good |
|
ISP medium 2 |
Good |
|
ISP medium 3 |
Good |
|
ISP medium 4 |
Very Good |
|
ISP medium 5 |
Good |
|
ISP medium 6 |
Better |
|
ISP medium 7 |
Good |
|
Bennett agar |
Good |
|
Nutrient agar |
Better |
|
Czapex Dox agar |
Good |
|
Kenknight's agar |
Very good |
|
Actinomycete isolation agar |
Very good |
Table 3 Biochemical and physiological properties of Streptomyces sp VITJS27
|
Microscopy |
|
Corn steep liquor |
+ |
|
Grams stain |
+ |
Sodium acetate |
- |
|
Colony pigmentation |
- |
Sodium citrate |
- |
|
Melanin pigmentation |
- |
Urea |
- |
|
Motility |
- |
Effect of Temperature* |
|
|
Soluble pigment |
- |
15oC |
- |
|
Carbon source |
28 oC |
+ |
|
|
D-glucose |
+ |
37 oC |
+ |
|
D-galactose |
- |
45 oC |
- |
|
Mannose |
- |
Effect of pH* |
|
|
Maltose |
+ |
5 |
- |
|
Lactose |
+ |
6 |
- |
|
Trehalose |
- |
7 |
+ |
|
Melibose |
- |
8 |
- |
|
Amino acid utilization |
9 |
- |
|
|
Cysteine |
- |
NaCl concentration |
|
|
Arginine |
- |
1% |
+ |
|
Therionine |
- |
2% |
- |
|
Alanine |
+ |
3% |
- |
|
Aspartic acid |
+ |
5% |
- |
|
Glycine |
- |
10% |
- |
|
Histidine |
- |
Hydrolysis |
|
|
Lysine |
- |
Starch hydrolysis |
+ |
|
Phenyl alanine |
+ |
Nitrate reduction |
- |
|
Tryptophan |
+ |
Gelatin liquefactions |
- |
|
Methionine |
+ |
Hemolysis on blood agar |
- |
|
Isoleucine |
- |
Esculin hydrolysis |
- |
|
Valine |
- |
H2S |
- |
|
Ornithine |
- |
Antibiotic resistance |
|
|
Asparagine |
- |
Streptomycin |
S |
|
Nitrogen Source |
Tetracyclin |
R |
|
|
Peptone |
+ |
Bacitracin |
R |
|
Yeast extract |
+ |
Kanamycin |
S |
|
Casein |
+ |
Ampicillin |
S |
|
Ammonium sulphate |
- |
Gentamicin |
R |
|
Ammonium nitrate |
+ |
Rifampacin |
R |
|
Ammonium citrate |
- |
Vancomycin |
R |
|
Beef extract |
+ |
Fluconazole |
R |
Fig 1 Pure culture of Streptomyces sp VITJS27 on starch casein agar
The potent isolate was streaked with cross-streak strategy Isolate is then screened for their inhibitory action against the human pathogenic microscopic organisms. The screening strategies were utilized to screen the actinomycetes for antibacterial action. The subjective approach was utilized to decide the scope of the isolates that are delicate to a potential anti-microbial. The quantitative approach gave the data about the yield of potential isolates namely JS27 that was propagated on ISP1 broth. All the test estimations were completed in triplicates and were communicated as a normal of three examinations. Disconnects JS26, JS27, and JS28 were exceptionally dynamic, while JS26 demonstrated less movement against the pathogenic microorganisms. JS27 strain exhibited antibacterial activity against Bacillus cereus (22 mm) and Enterococcus faecalis (25 mm) [Fig 2, 3]. The comparable antimicrobial action had been likewise reported against chosen multidrug safe microorganisms. 28, 29 The JS27 extract showed antioxidant activity with 89% percent at 1mg/mL [Fig 4]. Such reactivity has been generally used to test the capacity of a few mixes to go about as free radical foragers and to test the cancer prevention agent action. 32
Fig 2 Cross steak assay of Streptomyces sp VITJS27
(a) (b)
Fig 3 Antibacterial activity of Streptomyces sp VITJS27 crude extract: (a) Bacillus cereus (22 mm) (b) Enterococcus faecalis (25 mm)
Fig 4
GC-MS investigation of rough concentrate of Streptomyces Sp. obviously showed the nearness of natural metabolite Decanedioic acid,Bis (2-ethylhexyl) ester with the retention time at 24.9 min [Fig 5]
Fig 5
DISCUSSION:
CONCLUSION:
Marine actinomycetes, having bioactive property was isolated from soil samples,Vellore, India. These actinomycetes were characterized and identified as Streptomyces species. The active extract has proven to have various bioactivities which include anti-bacterial and anti-oxidant. These Streptomyces sp. strain are able to produce secondary metabolites responsible for the several bioactivities. These activities were checked for compound identification and analysis of GC-MS secondary metabolites. These active compound identified are previously has been stated for several bioactivities and also used as promoted drugs for bioactivities
CONFLICT OF INTEREST:
The authors declare that there is no conflict of interest in performing this study.
ACKNOWLEDGMENT:
We wish to thank VIT University for kind help and constant support
REFERENCES:
1. Berdy J. Bioactive microbial metabolites: A personal view. Journal of Antibiotics 2005, 58, 1–26.
2. Goodfellow M, O’Donnell AG. Search and discovery of industrially significant Actinomycetes. In: Baumberg S, Hunter IS, Rhodes PM, editors. Microbial Products: New Approaches, Society for General Microbiology Symposium No. 44. Cambridge: Cambridge University Press. 1989, 343–83.
3. Ventura M, Canchaya C, Tauch A., Chandra, G.; Fitzgerald, G.F.; Chater, K.F. Genomics of actinobacteria: Tracing the evolutionary history of an ancient phylum, Microbiology. Molecular Biology .Rev., 2007, 71, 495–548.
4. Ishida N, Miyazaki K, Kumagai K, Rikimaru M. Neocarzinostatin, an antitumor antibiotic of high molecular weight, isolation, physiochemical properties and biological activities, Journal of Antibiotics (Tokyo)., 1965, 18,68–76.
5. Wang Y, Zhang, Z S, Ruar T S, Wang Y M, Ali S M. Investigation of Actinomycetes diversity in the tropical rainforests of Singapore, Journal of Industrial Microbiology and Biotechnology 1999, 23, 178–87.
6. Okami Y, Okazaki T. Studies on marine microorganism’s isolation from the sea, Journal of Antibiotics 1972, 25, 456–60.
7. Baltz R H. Renaissance in antibacterial discovery from actinomycetes, Current Opinion Pharmacology, 2008, 8, 557–63.
8. Vining L C. Secondary metabolism, inventive evolution and biochemical diversity: A review, Gene.1992, 115, 135–40.
9. Edwards C. Isolation, properties and potential applications of thermophilic actinomycetes , Applied Biochemistry Biotechnology 1992, 42, 161–79.
10. Demain A. Cambridge: Cambridge University Press; Why do microorganisms produce antimicrobial? Proceedings of the society of General Microbiology 1995, 205–28.
11. Xu L H, Jiang Y, Li WJ, Wen ML, Li MG, Jiang CL. Streptomyces roseoalbus sp. nov.; an Actinomycete isolated from soil in Yunnan, China. Antonie Van Leeuwenhoek. 2009, 87, 189–94.
12. Watve M G Tickoo R, Jog M M Bhole B D. How many antibiotics are produced by genus Streptomyces Archieves of Microbiology 2001;176: 386–90.
13. Takizawa M, Colwell RR, Hill RT. Isolation and diversity of actinomycetes in the chasapeake bay, Applied Environmental Microbiology 1993, 59, 997–1002.
14. Mohankumar T, Sindhura S, Krishnan K . Characterization of Antioxidant activity of Streptomyces species VITTK3 isolated from Puducherry Coast, India. Journal of Advance Science Research 2010, 1(2), 46-52.
15. Loganathan Karthik, Gaurav Kumar, Kokati V Bhaskara Rao. Antioxidant activity of newly discovered lineage of marine actinobacteria. Asian Pacific Journal of Tropical Medicine , 2013, 6(4), 325-332
16. Gandhimathi R, Arunkumar M, Selvin J, Thangavelu T, Sivaramakrishnan S, Kiran G S, Shanmughapriya S, Natarajaseenivasan K. Antimicrobial potential of sponge associated marine actinomycetes. Journal de Mycologie Medicale.2008; 8:16-22.
17. Saadoun I, Hameed K M, Moussauui, A. Characterization and analysis of antibiotic activity of some aquatic actinomycetes. Microbios. 1999;99 :173–9.
18. Rahman M A. Islam M Z Islam M A. Antibacterial activities of Actinomycete isolates collected from soils of Rajshahi, Bangladesh .Biotechnology Research International. 2011; 857-925.
19. Pine L, Watson S J. Evaluation of an isolation and maintenance medium for Actinomyces species and related organisms, Journal of Laboratory and Clinical Medecine. 1959; 54: 107–14.
20. Waksman SA. Vol. 2. Baltimore: The Williams and Wilkins Company, The Actinomycetes, classification, identification and description of genera and species. 1961; 61–292.
21. Hopwood D A, Bibb M J, Chater K F, Kieser T, Bruton CJ, Kieser H M. Norwich, U.K. The John lnnes Foundation, Genetic Manipulation of Streptomyces, A Laboratory Manual. 1985.
22. Pepper I L, Garba C P Vol 2 San Diego CA: Elsevier Acadamic Press; Environmental Microbiology 2004; 37–49.
23. Nonomura, H. Key for classification and identification of 458 species of the Streptomycetes included in ISP. Journal of Fermentation Technology. 1989;52: 78–92.
24. Egorov N S. Antibiotics a Scientific Approach. Moscow: Mir Publishers, Antibiotic properties of microorganism cultivated in the Laboratory 1985;170–7.
25. Romankova AG, Zurabova E R, Fursenko MV, Sukharevich VI, Pronina, M I. Selection of strains of some antibiotic producing Actinomycetes during repeated passages in submerged cultures, Antibiotiki.1971; 16: 579–83.
26. Lakshmipatipathy, D.; Krishnan, K. v Antibacterial and antifungal activity of Streptomyces sp. VITDDK3 isolated from ennore coast, Tamil Nadu, India. Journal of Pharmaceutical Research Health Care. 2010; 2: 186–96.
27. Raja A, Prabakaran P. Preliminary screening of antimycobacterial effect of psychrophillic actinomycetes isolated from Manali ice point Himachal Predesh, Journal of Microbiology and Antimicrobials. 2011 ;3: 41–6.
28. Selvameenal L, Radhakrishnan M, Balagurunathan R. Antibiotic pigment from desert soil Actinomycetes; biological activity, purification and chemical screening, Indian Journal of Pharmaceutical Science. 2009; 71: 499–504.
29. Singh, S.; Kumar, P.; Gopalan, N.; Shrivastava, B.; Kuhad, C.; Chaudhary, H.S. .Isolation and partial characterization of actinomycetes with antimicrobial activity against multidrug resistant bacteria, Asian Pacific Journal of Tropical Biomedicine. 2012; S1147–50.
30. Subathradevi C , Nirmala Devi P, Jemimah naine S, Mohanasrinivasan V. Antibacterial and Antioxidant Property of Streptomyces cinnamonensis ,VITNS1 Isolated from Serkadu Region, Vellore, Tamil Nadu, India, Anti-Infective. Agents. 2014, 12 (2), 206-21.
31. Vellosa J C, Barbosa V F, Khalil N M, Freitas V A, Santos F M, Furlan M. Profile of Maytenus aquifolium action over free radicals and reactive oxygen species. Brazillian Journal of Pharmeutical Science. 2007; 43: 447-453.
32. Subathradevi C, Amritakumara, Nitin jain, Jemimahnaine S, Mohanasrinivasan, V. Screening of actinomyctes isolated from soil samples for antibacterial and antioxidant activity, International Journal of Pharmaceutical Science. 2013;5(4):0975-1491,
33. Dhivya B Arulanandu S B, Arumugam V, Ramachandran SS, Kandasamy D, Paramasivam N. Antioxidant Activity of Bacteria Associated with the Marine Sponge Tedania anhelans, Indian Journal of Microbiology. 2015; 55(1):13–18.
34. Hotam S, Chaudhary Jayprakash Yadav, Smriti Singh, Anil K Singh, Natrajan Gopalan. Antibacterial activity of actinomycetes isolated from different soil samples of Sheopur (A city of central India). Journal of Advance Pharmaceutical and Technology Research. 2013 ,4(2), 118–1s23.
35. Dhamodharan D, Subathra Devi C, Jemimah Naine S, Mohanasrinivasan V. A Preliminary Study of In vitro Antioxidant and Antibacterial Activity of Streptomyces gancidicus VITSD1 Isolated from Marine Soil. Current Bioactive Compounds. 2015;10:292-297
Received on 29.06.2017 Modified on 18.07.2017
Accepted on 22.08.2017 © RJPT All right reserved
Research J. Pharm. and Tech 2018; 11(7): 3123- 3127.
DOI: 10.5958/0974-360X.2018.00573.5